RVMD Revolution Medicines, Inc.
Healthcare$151.56-1.41%ClosedMarket Cap: $32.22B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$159.00
Target (Median)
$163.50
Target Range
$73.00 - $205.00
Upside from current price: 4.9%
Rating Distribution
4 Strong Buy17 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Needham | maintain | Buy | Buy |
| 2026-05-07 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-05-07 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-07 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-07 | Guggenheim | maintain | Buy | Buy |
| 2026-04-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-22 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-04-20 | Stifel | maintain | Buy | Buy |
| 2026-04-14 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-04-14 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-5.67 | $778.8M | 16 |
| Sun Dec 31 | $-2.22 | $1.78B | 15 |
| Mon Dec 31 | $3.12 | $3.50B | 10 |
| Tue Dec 31 | $9.23 | $5.43B | 6 |